TFE3-renal carcinoma in an adult patient: A case with strong expression of phosphorylated hepatocyte growth factor (HGFR)/Met

Pathology Research and Practice

Volumn 205, Issue 1, 2009, Pages 57-61

  Sagara, Yuji ^a   Miyata, Yasuyoshi ^a   Nomata, Koichiro ^a   Abe, Kuniko ^b   Eguchi, Jiro ^a   Hayashi, Tomayoshi ^b   Sakai, Hideki ^a   Kanda, Shigeru ^c   Kanetake, Hiroshi ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Hepatocyte growth factor receptor Met; Immunohistochemistry; Phosphorylation; TFE 3 renal carcinoma

Indexed keywords

CHROMOSOME PROTEIN; INTERFERON; INTERLEUKIN 2; SCATTER FACTOR; TFE3 PROTEIN; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ADULT; ARTICLE; CANCER IMMUNOTHERAPY; CANCER INVASION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FOLLOW UP; HEMATURIA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LAPAROSCOPIC SURGERY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; NEPHRECTOMY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; THORAX RADIOGRAPHY; TUMOR GROWTH; UPREGULATION;

ADULT; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CARCINOMA, RENAL CELL; FATAL OUTCOME; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY NEOPLASMS; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; NEPHRECTOMY; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; RECEPTORS, GROWTH FACTOR; UP-REGULATION;

EID: 57249089051     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2008.08.001     Document Type: Article

References (11)

1. Argani P., and Ladanyi M. Renal carcinomas associated with Xp11.2 translocations/TFE3 gene fusions. In: Eble J.M., Sauter G., Epstein J., and Sesterhenn I. (Eds). Pathology and Genetics of Tumors of the Urinary System & Male Genital Organs (2004), IARC Press, Lyon 37-38
2. Argani P., Lai P., Huchinson B., Lui M.Y., Reuter V.E., and Ladanyi M. Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am. J. Surg. Pathol. 27 (2003) 750-761
3. Argani P., Olgac S., Tickoo S.K., Goldfischer M., Moch H., Chan D.Y., Eble J.N., Bonsib S.M., Jimero M., Lloreta J., Billis A., Hicks J., De Marzo A.M., Leuter V.E., and Ladanyi M. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum. Am. J. Surg. Pathol. 31 (2007) 1149-1160
4. Bruder E., Passera O., Harms D., Leuschner I., Ladanyi M., Argagni P., Eble J.N., Struckmann K., Schraml P., and Mock H. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am. J. Surg. Pathol. 28 (2004) 1117-1132
5. Gentile A., Trusolino L., and Comoglio P.M. The Met tyrosine kinase receptor in development and cancer. Cancer Metastasis Rev. 27 (2008) 85-94
6. Meyer P.N., Clark J.J., Flanigan R.C., and Picken M.M. Xp11.2 translocation renal cell carcinoma with very aggressive course in five adults. Am. J. Clin. Pathol. 128 (2007) 70-79
7. D. Mitropoulos, A. Petrolekas, I. Anastasiou, I. Adamakis, A. Kyroudi-Voulgari, E. Serafetinides, A. Zervas, Difference of presentation characteristics of renal cell carcinoma in the last 25 years: a single center experience, J. Cancer Res. Clin. Oncol. in press.
8. Miyata Y., Kanda S., and Kanetake H. Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma. Clin. Cancer Res. 15 (2006) 4876-4881
9. Müller-Höcker J., Babaryka G., Scmid I., and Jung A. Overexpression of cyclin D1, D3, and p21 in an infantile renal carcinoma with Xp11.2 TFE3-gene fusion. Pathol. Res. Pract. 204 (2008) 589-597
10. Tsuda M., Davis I.J., Argani P., Shukla N., McGill G.G., Nagai M., Saito T., Laé M., Fisher M.L., and Ladanyi M. TFE3 fusion activate MET signaling by transcriptional up-regulation, defining another class of tumors as candidates for therapeutic MET inhibition. Cancer Res. 67 (2007) 919-929
11. Wernert. Multiple roles of tumour stroma. Virchows Arch. 430 (1997) 433-443